Clinical trial
Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok…
NCT00006327 · VaxGen, Industry · Completed
Key facts
| NCT number | NCT00006327 |
|---|---|
| Title | Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand |
| Official title | A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand |
| Lead sponsor | VaxGen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity |
| Intervention type | Biological |
| Interventions | MN rgp120/HIV-1 and A244 rgp120/HIV-1 |
| Enrollment | 2,500 |
| Start date | Mar 1, 1999 |
| Completion | Aug 1, 2000 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: